Toronto Star

Pot sector pipes up on U.S. investment

- ALEXANDRA POSADZKI THE CANADIAN PRESS

Marijuana industry insiders say they have met with the operators of Canada’s largest stock exchange to devise a policy on investing in the U.S., where growing and selling cannabis violates federal laws.

Lawyers who work with publicly traded Canadian marijuana producers say there is an unwritten rule that companies traded on the Toronto Stock Exchange or the TSX Venture Exchange are not permitted to have investment­s in the U.S. cannabis sector. TMX Group — the company that operates both the TSX and Venture Exchange — is now looking to codify that policy, particular­ly given the uncertaint­y stemming from the change in administra­tion in the U.S., according to industry observers.

“The big issue that’s got the exchanges taking a harder look really relates to the change in administra­tion since President Trump’s election,” said Hugo Alves, corporate and commercial partner at Bennett Jones LLP.

“That is causing a bit of a chilling effect.”

Although more than two dozen U.S. states have decriminal­ized the drug, either for medicinal or recreation­al use, marijuana remains a Schedule 1 narcotic in the United States, and its possession, cultivatio­n, usage and sale contravene federal laws. When Barack Obama was president, the U.S. government was choosing not to enforce the federal marijuana laws in states that had voted to decriminal­ize the drug.

But the new administra­tion has a much harsher, anti-marijuana stance, creating risk for shareholde­rs who have exposure to the U.S. cannabis space. TMX Group would not confirm that it is holding meetings with the marijuana sector in order to formulate a policy regarding U.S. investment­s, saying in an email that it does not comment on “individual issuer affairs.”

“We evaluate all issuers and their eligibilit­y to list, and to remain listed on our markets, according to our published policies and guidance,” spokespers­on Shane Quinn said.

But Vic Neufeld, the president and CEO of Aphria, says he has attended such meetings.

The Leamington, Ont.-based company first dipped its toes into the U.S. market over a year ago with an investment in Copperstat­e Farms, a medical marijuana producer in Arizona. Neufeld said the company fully disclosed the investment.

“The regulators knew everything,” Neufeld said.

“We didn’t hide anything. In fact, we over-disclosed.”

It wasn’t until Aphria started making headlines about an investment in Florida — through a new company it is creating called Liberty Health Sciences Inc. — that the regulators started to take notice, Neufeld said.

Now, the company is in meetings with the TSX to discuss investing in jurisdicti­ons whose regulation­s differ from Canada’s, Neufeld said.

“The exchange is in the process of trying to develop the policy,” Neufeld said.

Other licensed producers are also meeting with the exchange to discuss the issue, as many of them would like to expand south of the border, according to lawyers familiar with the discussion­s.

Bennett Jones partner Aaron Sonshine said there are also dozens of U.S.-based companies which want to list on Canadian exchanges in order to raise funds.

“We’ve had a number of clients interested in listing U.S. companies up here,” said Sonshine, adding that anecdotall­y, he’s heard there might be close to 100 U.S. marijuana companies looking to list in Canada.

That poses a dilemma for the ex- change, which could use the revenue at a time when listings are lagging, but also wishes to protect investors from political uncertaint­y, Sonshine said.

Kristen Rose, a spokespers­on for the Ontario Securities Commission, said the watchdog is “aware of the concerns raised” and has been “actively engaging with the TSX.”

The Canadian Securities Exchange, or the CSE, has been more permissive, says Andrew Powers, a partner with Borden Ladner Gervais LLP.

“They are focused more on disclosure rather than prohibitio­n,” Powers says.

“The TSX doesn’t want their listed issuers to be making these investment­s. The CSE will permit it, but they are requiring detailed disclosure of risk factors regarding their investment­s in the United States. I guess the concept is ‘buyer beware.’ ”

 ?? RICHARD VOGEL/THE ASSOCIATED PRESS FILE PHOTO ?? More than two dozen U.S. states have decriminal­ized marijuana, still a Schedule 1 narcotic in the United States.
RICHARD VOGEL/THE ASSOCIATED PRESS FILE PHOTO More than two dozen U.S. states have decriminal­ized marijuana, still a Schedule 1 narcotic in the United States.

Newspapers in English

Newspapers from Canada